N-of-1 Trials Take on Challenges in Health Care

From personalizing clinical practice to aiding biomedical research, individualized clinical trials have been heralded as a solution to several problems plaguing modern medicine. But they’ve yet to be widely adopted.

Written byCatherine Offord
| 15 min read
N-of-1 trials

Register for free to listen to this article
Listen with Speechify
0:00
15:00
Share

ABOVE: MODIFIED FROM
© ISTOCK.COM, Varijanta

For a few months in the first half of 2019, Chris Payze started each morning at home in Queensland, Australia, by jotting down answers to a series of questions. What time did I go to bed? How many times did I wake up? Speaking to The Scientist this April, 71-year-old Payze said she’d gotten “really into the groove” of this daily routine. “It only takes me about five minutes.”

She recorded the information for a trial of melatonin, a hormone that regulates sleep-wake cycles and is often taken orally as a sleep aid, although it’s not clear how well it works. Payze has Parkinson’s disease, and for the last couple years, she, like many people with the condition, has been dealing with insomnia. “I just have awful trouble sleeping at night,” she explains. While she doesn’t feel sleep-deprived, the interrupted sleep “is just annoying me. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Published In

On Target July Issue The Scientist
July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS